Skip to main content
Fig. 5 | Journal of Hematology & Oncology

Fig. 5

From: A non-internalised CD38-binding radiolabelled single-domain antibody fragment to monitor and treat multiple myeloma

Fig. 5

a Time-dependent biodistribution of 177Lu-DTPA-2F8 i.v. co-injected with gelofusin 150 mg/kg into RPMI 8226 CD38+ tumour-bearing mice (105 cells injected subcutaneously in the left back side). Values are represented as % IA/g, obtained after dissection and further detailed in Additional file 1: Table 7. Data are presented as mean ± SD (n = 3). b Comparison of renal and tumour retention observed for #2F8 labelled with different radioisotopes (n = 3), alone or with 150 mg/kg gelofusin. Data are expressed as mean ± SD

Back to article page